Shelter Pharma — 360° view

Shelter Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹45 crore and net profit of ₹5.21 crore for the September 2026 quarter.

Shelter Pharma (BSE: SHELTER) closed at ₹45.80 on 20 Nov 2026, up 8.0% over the past year. Its market capitalisation is ₹77 crore and it trades at 7.9 times earnings.

Share price
₹45.80 (20 Nov 2026)
Market cap
₹77 Cr (20 Nov 2026)
P/E
7.92 (20 Nov 2026)
Revenue
₹45 Cr (September 2026 quarter)
Net profit
₹5 Cr (September 2026 quarter)
ROCE
20.4% (FY26)
ROE
15.1% (FY26)
Book value
₹49.0 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹55.88 / ₹23.00 (20 Nov 2026)
1-year return
8.0% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
BSE: SHELTER

Incorporated in 2007, Shelter Pharma Ltd manufactures pharma products including food supplements for animals

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.